Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Radiation Therapy in Hematologic Malignancies (eBook)

An Illustrated Practical Guide
eBook Download: PDF
2016 | 1st ed. 2017
X, 203 Seiten
Springer International Publishing (Verlag)
978-3-319-42615-0 (ISBN)

Lese- und Medienproben

Radiation Therapy in Hematologic Malignancies -
Systemvoraussetzungen
96,29 inkl. MwSt
(CHF 93,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This book is designed to assist practitioners in managing patients who present with difficult cases of the most common hematological malignancies. The scenarios covered are those that are likely to be encountered in patients with the various forms of Hodgkin's lymphoma, non-Hodgkin's lymphoma, and leukemia. In each of the three sections devoted to these malignancies, multiple cases are presented. The case discussions follow a standard format. A clinical description is followed by a pathological description documenting information relevant to diagnosis and by details of staging work-up, including images. The treatment options are then discussed at length, highlighting relevant literature for each option. Finally, the treatment delivered is identified and images of the planning technique/modality used are provided. This book will be an invaluable aid to decision making for radiation oncologists and will also be of interest for hematologists.

Bouthaina Dabaja is an Associate Professor in Radiation Oncology, Section chief of Hematologic Malignancies in the department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. Dr. Dabaja received her medical degree from the Lebanese University in Lebanon. She was trained in Internal Medicine and Medical Oncology at the American University of Beirut in Lebanon. Completed her training in Medical Oncology and Radiation Oncology at University of Texas MD Anderson Cancer Center.
Dr. Dabaja is the Section chief of hematologic malignancies in the radiation oncology where she overseas the clinical and research activities and assist in the research development, specifically advancing the application of advanced technology in the treatment of both lymphoma and leukemia. Dr. Dabaja special interest, reflected by her publications in the field, is conducting research in an effort to reintroduce radiation into the treatment of hematologic malignancies with fewer

side effects to maintain its long-term benefit.

Andrea Ng is a Professor of Radiation Oncology at Harvard Medical School and Associate Clinical Director of Radiation Oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute.
Dr. Ng received her medical degree from Harvard Medical School, Boston, Massachusetts. She was trained in Radiation Oncology (Joint Center for Radiation Therapy, Boston, Massachusetts). Her research work focuses on analyses of treatment outcome as well as short- and long-term effects of radiation therapy in lymphoma patients, optimal follow-up of long-term survivors, and development of novel radiation therapy approaches to limit late effects of treatments while preserving its efficacy.  

Bouthaina Dabaja is an Associate Professor in Radiation Oncology, Section chief of Hematologic Malignancies in the department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. Dr. Dabaja received her medical degree from the Lebanese University in Lebanon. She was trained in Internal Medicine and Medical Oncology at the American University of Beirut in Lebanon. Completed her training in Medical Oncology and Radiation Oncology at University of Texas MD Anderson Cancer Center.Dr. Dabaja is the Section chief of hematologic malignancies in the radiation oncology where she overseas the clinical and research activities and assist in the research development, specifically advancing the application of advanced technology in the treatment of both lymphoma and leukemia. Dr. Dabaja special interest, reflected by her publications in the field, is conducting research in an effort to reintroduce radiation into the treatment of hematologic malignancies with fewer side effects to maintain its long-term benefit.Andrea Ng is a Professor of Radiation Oncology at Harvard Medical School and Associate Clinical Director of Radiation Oncology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute.Dr. Ng received her medical degree from Harvard Medical School, Boston, Massachusetts. She was trained in Radiation Oncology (Joint Center for Radiation Therapy, Boston, Massachusetts). Her research work focuses on analyses of treatment outcome as well as short- and long-term effects of radiation therapy in lymphoma patients, optimal follow-up of long-term survivors, and development of novel radiation therapy approaches to limit late effects of treatments while preserving its efficacy.  

​Part I: Hodgkin’s Lymphoma: early stage favourable and unfavourable.- Advanced stage.- Primary refractory.- Relapsed Hodgkin’s in the setting of transplant.- Part II: Non Hodgkin’s Lymphoma: Diffuse Large Cell Lymphoma.- Early stage.- Advanced stage.- Refractory/palliative.- Follicular lymphoma: Early stage, grade 1,2.- Advanced stage/palliative.- Extranodal marginal zone: Gastrointestinal origin.- Non-gastrointestinal origin.- Primary mediastinal lymphoma.- Plasmacytoma/multiple myeloma.- Lymphoblastic lymphoma.- Primary CNS lymphoma.- Primary testicular lymphoma.- Mantle cell lymphoma.- Primary skin lymphoma including anaplastic large cell and mycosis fungoides.- Part III: Leukemia: craniospinal irradiation.- treatment of chloromas.

Erscheint lt. Verlag 26.10.2016
Zusatzinfo X, 203 p. 124 illus., 102 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Innere Medizin
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte Hematological Malignancies • Hodgkin’s lymphoma • leukemia • Lymphoma • Non-Hodgkin's Lymphoma • radiation oncology • Radiaton Oncology
ISBN-10 3-319-42615-X / 331942615X
ISBN-13 978-3-319-42615-0 / 9783319426150
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 14,5 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich